Establishment of a Human Thyroid Tissue and Blood Sample Repository

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-004151
    Sponsor Protocol Number: 15-004151

About this study

The purpose of this study is to establish a human biobank of thyroid-derived tissues and blood samples from patients with thyroid disorders at Mayo Clinic in Rochester.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Age 18 years or older
  • Able to consent
  • Will undergo thyroidectomy or thyroid related tumor resections at Mayo Clinic in Rochester for the following reasons:
    • Thyroid nodules (benign, indeterminate, suspicious or malignant) Graves’ disease
    • Goiter
    • Biopsy proven thyroid cancers. 
  • Thyroid cancer presenting to Endocrine or Endocrine Oncology clinics for surveillance of their disease

Exclusion Criteria:

  •  Age <18 years
  • Pregnant women
  • Children
  • Prisoners
  • Institutionalized individuals
  • Others who are likely to be vulnerable

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mabel Ryder, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available